KINTOR PHARMACEUTICAL LIMITED disclosed its monthly return for equity securities on The Stock Exchange of Hong Kong Limited for the period ended January 31, 2026. According to the announcement, the authorized share capital remained at 700,000,000 ordinary shares with a par value of USD 0.0001 each, totaling USD 70,000. This figure remained unchanged compared to the close of the preceding month.

The announcement confirmed that the total number of issued shares, excluding treasury shares, stood at 498,660,100, with no change from the preceding month. The company also indicated compliance with the applicable public float requirement, which is 25% of the total issued shares. The document noted no new share options, warrants, convertibles, or other arrangements related to the issuance of shares during this period.